B6E Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Swedish Orphan Biovitrum AB (publ)

Watchlist Manager

Watchlist

Price: 42.8 EUR 4.34% Market Closed

Market Cap: €14.5B

S	Swedish Orphan Biovitrum AB (publ) F:B6E	SE
	Bankinter SA MAD:BKT	ES
I	IONOS Group SE DUS:IOS	DE
	Audax Renovables SA F:54F	ES
	FirstRand Ltd OTC:FANDY	ZA
	Clover Health Investments Corp NASDAQ:CLOV	US
	Genfit SA NASDAQ:GNFT	FR

Profitability Summary

Swedish Orphan Biovitrum AB (publ)'s profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

78%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

77% > 78%

Healthy Operating Margin

29%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

24% > 29%

Low Net Margin

Sustainable 3Y Average Net Margin

10%

Declining Net Margin

16% > 3%

Exceptional Free Cash Flow Margin

14%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

Positive 3Y Average ROIC

20%

ROIC is Increasing

6% > 17%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.